Our dual aims were as follows: (1) to classify new or recurrent myocardial infarctions (MI) in patients with stable atherosclerosis using the Universal Definition of MI classification system; and (2) to characterize the effects of vorapaxar, a first-in-class platelet protease-activated receptor -1 antagonist, on new or recurrent MI.

Universal Classification System Type of Incident Myocardial Infarction in Patients With Stable Atherosclerosis: Observations From Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P)-TIMI 50

DE FERRARI, GAETANO;
2016-01-01

Abstract

Our dual aims were as follows: (1) to classify new or recurrent myocardial infarctions (MI) in patients with stable atherosclerosis using the Universal Definition of MI classification system; and (2) to characterize the effects of vorapaxar, a first-in-class platelet protease-activated receptor -1 antagonist, on new or recurrent MI.
2016
5
7
1
8
atherosclerosis; cardiovascular disease; myocardial infarction; platelet inhibitor
Kidd, Stephen K; Bonaca, Marc P; Braunwald, Eugene; DE FERRARI, GAETANO; Lewis, Basil S; Merlini, Piera A; Murphy, Sabina A; Scirica, Benjamin M; White, Harvey D; Morrow, David A.
File in questo prodotto:
File Dimensione Formato  
J Am Heart Assoc. 2016.Kidd.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 495.29 kB
Formato Adobe PDF
495.29 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1735872
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact